氨甲环酸给药与初次全髋和全膝关节置换术后假体周围关节感染几率降低相关:一项全国数据库分析
基于Premier医疗数据库2012至2016年择期初次全髋或全膝关节置换患者,分析手术当日氨甲环酸给药与90天内假体周围关节感染的关系。在914,990例患者中,46.0%手术当日接受氨甲环酸,0.13%在90天内发生感染;校正混杂因素后,氨甲环酸使用与90天内感染几率显著降低相关(OR 0.49 [0.69, 0.91])。
要点
- 在914,990例初次全髋或全膝关节置换患者中,46.0%于手术当日接受氨甲环酸。
- 90天内假体周围关节感染发生率为0.13%。
- 校正后氨甲环酸与90天内感染几率显著降低相关(OR 0.49 [0.69, 0.91])。
核心结论
- 全膝和全髋关节置换手术当日给予氨甲环酸与术后90天内假体周围关节感染几率统计学显著降低相关。
- 作者认为氨甲环酸可能在降低关节置换术后假体周围关节感染的努力中发挥重要作用。
- 氨甲环酸贡献于这种降低的确切机制和理想剂量需要进一步研究。
研究设计与样本
- 查询Premier医疗数据库,纳入2012至2016年择期住院初次全髋置换或全膝置换的ICD-9编码病例。
- 暴露为手术当日氨甲环酸给药,结局为住院期间或90天内假体周围关节感染。
- 采用多水平多变量逻辑回归(SAS 9.4版,SAS研究所,美国北卡罗来纳州卡里)分析氨甲环酸给药或其他协变量是否为感染的显著预测因素。
主要发现
- 共914,990例全关节置换患者,46.0%在手术当日接受氨甲环酸。
- 0.13%的患者在90天内发生假体周围关节感染。
- 校正患者和医院相关协变量后,氨甲环酸使用与手术90天内假体周围关节感染几率显著降低相关(OR 0.49 [0.69, 0.91])。
局限性
- 氨甲环酸贡献于假体周围关节感染降低的确切机制和理想剂量需要进一步研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Tranexamic acid (TXA) for the reduction of blood loss in orthopedic surgery is coming into greater adoption. Because TXA administration lowers the incidence of blood transfusion and of hematoma formation, risk factors for infection, we asked whether TXA use might be associated with a lower incidence of periprosthetic joint infection (PJI) following orthopedic surgery. METHODS: We queried the Premier Healthcare database for ICD-9 codes corresponding to elective inpatient primary total hip replacement (THR) or total knee replacement (TKR) from 2012 to 2016, TXA administration on the day of surgery, and PJI during the hospital stay or within 90 days. We performed a multilevel multivariable logistic regression (SAS version 9.4. SAS Institute, Cary, NC) to determine if TXA administration or other covariates were a significant predictor of infection. RESULTS: Among 914,990 total joint arthroplasty patients, 46.0% received TXA on the day of surgery. 0.13% developed PJI within 90 days. After adjusting for patient and hospital-related covariates, TXA use was associated with significantly lower odds of PJI within 90 days of surgery (OR 0.49 [0.69, 0.91]). CONCLUSION: Administration of TXA on the day of surgery in total knee and total hip arthroplasty was associated with a statistically significant decreased odds of PJI in the first 90 days. We therefore conclude that TXA might play an important role in our attempts to decrease PJI after joint arthroplasty. The exact mechanisms and ideal dosage by which TXA can contribute to such a reduction need further study.
引用
- Hong GJ, Wilson LA, Liu J, et al. Tranexamic Acid Administration is Associated With a Decreased Odds of Prosthetic Joint Infection Following Primary Total Hip and Primary Total Knee Arthroplasty: A National Database Analysis. J Arthroplasty. 2020. PMID: 33127237. doi:10.1016/j.arth.2020.10.003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。